PMID- 38030246
OWN - NLM
STAT- MEDLINE
DCOM- 20231201
LR  - 20240122
IS  - 2044-6055 (Electronic)
IS  - 2044-6055 (Linking)
VI  - 13
IP  - 11
DP  - 2023 Nov 29
TI  - Depression and glycaemic control among adult patients with type 2 diabetes: a 
      cross-sectional study in a comprehensive specialised hospital, Jigjiga, Ethiopia.
PG  - e073123
LID - 10.1136/bmjopen-2023-073123 [doi]
LID - e073123
AB  - OBJECTIVES: The primary objective of this study was to evaluate the prevalence of 
      depression and its sociodemographic predictors, clinical predictors and glycaemic 
      control among adult patients with type 2 diabetes at Sheik Hassan Yabare 
      Comprehensive Specialized Hospital (SHYCSH), Jigjiga, Ethiopia. DESIGN: A 
      hospital-based cross-sectional study was conducted. SETTING: Patients with type 2 
      diabetes mellitus (T2DM) at Sheik Hassan Yabare Comprehensive Specialized 
      Hospital, for chronic follow-up from 3 October 2022 to 13 November 2022. 
      PARTICIPANTS: Randomly selected 278 patients with T2DM age 18 years and older, 
      with a duration of 1 year or more since diagnosis, who had a diabetic follow-up 
      at SHYCSH. MAIN OUTCOME MEASURES: Depression was assessed using the Patient 
      Health Questionnaire. RESULTS: A total of 263 participants were included, with a 
      response rate of 94.6%. Of the respondents, 134 (51%) were male, making up more 
      than half of the total. The overall prevalence of depression was 47.1% (95% CI 
      41.1 to 53.2). Depression was further classified, as follows, based on its 
      severity: the majority (66 or 25.1%) had mild depression, followed by 44 (16.7%) 
      with moderate depression, 9 (3.4%) with moderately severe depression and 5 (1.9%) 
      with severe depression. A multivariable logistic regression analysis indicated 
      that poor glycaemic control (adjusted OR (AOR)=1.93; 95% CI 1.05 to 3.53), DM 
      complications (AOR=2.02; 95% CI 1.09 to 3.74) and DM duration of 6-10 years since 
      diagnosis (AOR=2.29; 95% CI 1.21 to 4.34) were independently associated with 
      depression. CONCLUSIONS: Our study revealed a significant burden of depression 
      among patients with T2DM receiving follow-up care at the hospital. Glycaemic 
      control, the presence of complications and a longer duration of diabetes were 
      identified as predictors of depression. Therefore, concerned stakeholders should 
      work to improve blood sugar control and promote healthy behaviour, particularly 
      among those with complications or who have been sick for an extended period of 
      time.
CI  - (c) Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No 
      commercial re-use. See rights and permissions. Published by BMJ.
FAU - Ali, Seid Yimam
AU  - Ali SY
AUID- ORCID: 0009-0001-0240-7897
AD  - Medicine, Jigjiga University, Jigjiga, Somali, Ethiopia seidyimam4500@gmail.com.
FAU - Seid, Ahmed Muhye
AU  - Seid AM
AD  - Public Health, Dire Dawa University, Dire Dawa, Ethiopia.
FAU - Hassen, Kalkidan
AU  - Hassen K
AD  - Nutrition and Dietetics, Jimma University College of Public Health and Medical 
      Sciences, Jimma, Oromia, Ethiopia.
FAU - Abebe, Samuel Taddese
AU  - Abebe ST
AD  - Biomedical Science, Jimma University College of Public Health and Medical 
      Sciences, Jimma, Oromia, Ethiopia.
FAU - Banjaw, Zelalem
AU  - Banjaw Z
AUID- ORCID: 0000-0002-1517-8114
AD  - Biomedical Science, Jimma University College of Public Health and Medical 
      Sciences, Jimma, Oromia, Ethiopia.
FAU - Ibrahim, Mohammed
AU  - Ibrahim M
AD  - Biomedical Science, Jimma University College of Public Health and Medical 
      Sciences, Jimma, Oromia, Ethiopia.
LA  - eng
PT  - Journal Article
DEP - 20231129
PL  - England
TA  - BMJ Open
JT  - BMJ open
JID - 101552874
SB  - IM
MH  - Humans
MH  - Adult
MH  - Male
MH  - Adolescent
MH  - Female
MH  - *Diabetes Mellitus, Type 2/complications/epidemiology
MH  - Cross-Sectional Studies
MH  - Depression/epidemiology
MH  - Ethiopia/epidemiology
MH  - Glycemic Control
MH  - Hospitals, Special
PMC - PMC10689400
OTO - NOTNLM
OT  - DIABETES & ENDOCRINOLOGY
OT  - Depression & mood disorders
OT  - NEUROLOGY
COIS- Competing interests: None declared.
EDAT- 2023/11/30 00:42
MHDA- 2023/12/01 06:44
PMCR- 2023/11/29
CRDT- 2023/11/29 20:53
PHST- 2023/12/01 06:44 [medline]
PHST- 2023/11/30 00:42 [pubmed]
PHST- 2023/11/29 20:53 [entrez]
PHST- 2023/11/29 00:00 [pmc-release]
AID - bmjopen-2023-073123 [pii]
AID - 10.1136/bmjopen-2023-073123 [doi]
PST - epublish
SO  - BMJ Open. 2023 Nov 29;13(11):e073123. doi: 10.1136/bmjopen-2023-073123.